Post-translational regulation of the low-density lipoprotein receptor : PCSK9 as a therapeutic target

Post-translational regulation of the low-density lipoprotein receptor : PCSK9 as a therapeutic target

Bibliographic Details
Main Author:	Duff, Christopher
Published:	University of Leeds 2010
Online Access:	https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.749285

Similar Items

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
by: Yue-Wei Qian, et al.
Published: (2007-07-01)

Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding
by: Hong-mei Gu, et al.
Published: (2013-12-01)

Asociation of PCSK9 with Low Density Lipoproteins (LDL) in the Regulation of LDL-Cholesterol Levels
by: Sarkar, Samantha Khadija
Published: (2015)

High-Throughput Screening Identifies MicroRNAs Regulating Human PCSK9 and Hepatic Low-Density Lipoprotein Receptor Expression
by: Coen van Solingen, et al.
Published: (2021-07-01)

The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol
by: Poirier S, et al.
Published: (2013-10-01)

The Regulation of PCSK9 Structure and Function Through Lipoprotein Interactions
by: Sarkar, Samantha Khadija
Published: (2019)

PCSK9: A Potential Therapeutic Target for Sepsis
by: Yuan Yuan, et al.
Published: (2020-01-01)

Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels.
by: Chan Joo Lee, et al.
Published: (2017-01-01)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).
by: Maryssa Canuel, et al.
Published: (2013-01-01)

Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells.
by: Hung-Chen Chen, et al.
Published: (2016-01-01)

PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
by: V Z Lankin, et al.
Published: (2018-09-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Phage display for targeting PCSK9
by: Nicola Ferri
Published: (2021-03-01)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
by: Olga Afanasieva, et al.
Published: (2020-10-01)

PCSK9 and its clinical importance with the new therapeutic targets against dyslipidemia
by: Carlos Eduardo dos Santos Ferreira, et al.

Post-transcriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity.
by: MF Sharkey, et al.
Published: (1990-12-01)

Aspects of low density lipoprotein receptor gene regulation
by: Brooks, David Graham
Published: (1994)

REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR SPLICING EFFICIENCY
by: Ling, I-Fang
Published: (2009)

Candidate Gene Analysis Reveals Strong Association of CETP Variants With High Density Lipoprotein Cholesterol and PCSK9 Variants With Low Density Lipoprotein Cholesterol in Ghanaian Adults: An AWI-Gen Sub-Study
by: Godfred Agongo, et al.
Published: (2020-10-01)

Low density Lipoprotein cholesterol target: Changing goal posts
by: Ganapathi Bantwal, et al.
Published: (2012-01-01)

Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction
by: Stefano Toldo, PhD, et al.
Published: (2017-10-01)

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
by: Tingting Li, et al.
Published: (2021-01-01)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo
by: Elise F. Villard, PhD, et al.
Published: (2016-10-01)

Effect of <it>Porphyromonas gingivalis</it> infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice
by: Miyazawa Haruna, et al.
Published: (2012-09-01)

Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
by: Ranheim Trine, et al.
Published: (2007-03-01)

Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts
by: My-Anh Nguyen, et al.
Published: (2014-02-01)

PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
by: Ji Soo Lee, et al.
Published: (2021-04-01)

Development of Inhibitors of Human PCSK9 as Potential Regulators of LDL-Receptor and Cholesterol
by: Alghamdi, Rasha Hassen
Published: (2014)

Quercetin-3-glucoside increases low-density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture
by: Majambu Mbikay, et al.
Published: (2014-01-01)

Magnetic Resonance Imaging Detection of Tumor Cells by Targeting Low-Density Lipoprotein Receptors with Gd-Loaded Low-Density Lipoprotein Particles
by: Simonetta Geninatti Crich, et al.
Published: (2007-12-01)

The PCSK9 decade
by: Gilles Lambert, et al.
Published: (2012-12-01)

New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects
by: Qidi Ying, et al.
Published: (2021-02-01)

Studies on the regulation of low density lipoprotein receptors in cultured human fibroblasts.
Published: (1984)

N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors
by: Zhang CG, et al.
Published: (2014-06-01)

Oxidized low‐density lipoproteins as a novel risk factor and therapeutic target for ACM
by: Hoyee Tsui, et al.
Published: (2021-09-01)

High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice1[S]
by: Franz Rinninger, et al.
Published: (2014-09-01)

Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.
by: Rocco Romagnuolo, et al.
Published: (2017-01-01)

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9
by: Adorni MP, et al.
Published: (2017-12-01)

Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
by: Camilla Gustafsen, et al.
Published: (2017-09-01)

LOW DENSITY LIPOPROTEIN RECEPTOR AND ALZHEIMERS DISEASE
by: Gopalraj, Rangaraj K.
Published: (2009)